A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes
Diabetes Therapy - Trang 1-14 - 2024
Tóm tắt
The psychological burden of type 1 diabetes mellitus (T1DM) is considerable. The condition affects the daily lives of adults living with T1DM (ALWT1DM) in many ways. International guidelines highlight the importance of providing psychological support to ALWT1DM to improve health outcomes and well-being. We conducted a systematic literature review of randomised controlled trials (RCTs) to identify the evidence on the impact of psychological interventions on glycaemic control and psychological outcomes in ALWT1DM. Literature searches of Medline, Embase, Cochrane Central Register of Controlled Trials, PsycInfo, and the grey literature were performed to identify relevant RCTs, published in English, from 2001 onward. Fourteen RCTs of ten psychological interventions in ALWT1DM were eligible and included in the qualitative synthesis. The studies varied considerably in terms of duration, target population, endpoints, and efficacy. Overall, psychological interventions did not perform significantly better than control treatments in improving glycaemic control, although selected patient groups did report benefits from some psychological intervention types, such as cognitive behavioural therapy. Although most of the psychological interventions produced small, nonsignificant improvements in self-reported patient functioning, some treatments were effective in reducing diabetes distress and improving mental health, even if no impact on glycaemic control was observed. Current guidelines for the treatment of T1DM recommend access to psychological services; however, there is a paucity of high-quality evidence from clinical trials on the effectiveness or preferred structure of psychological support. There is a clear need for more rigorous, large-scale, international research to address the efficacy of psychological interventions in ALWT1DM.
Tài liệu tham khảo
Green A, Hede SM, Patterson CC, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64(12):2741–50. https://doi.org/10.1007/s00125-021-05571-8.
van Duinkerken E, Snoek FJ, de Wit M. The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabet Med. 2020;37(4):555–63. https://doi.org/10.1111/dme.14216.
Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126–40. https://doi.org/10.2337/dc16-2053.
Cho MK, Kim MY. What affects quality of life for people with type 1 diabetes? A cross-sectional observational study. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph18147623.
Benkel I, Arnby M, Molander U. Living with a chronic disease: a quantitative study of the views of patients with a chronic disease on the change in their life situation. SAGE Open Med. 2020. https://doi.org/10.1177/2050312120910350.
Reddy M, Rilstone S, Cooper P, Oliver NS. Type 1 diabetes in adults: supporting self management. BMJ. 2016;352: i998. https://doi.org/10.1136/bmj.i998.
Winkley K, Upsher R, Stahl D, et al. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabet Med. 2020;37(5):735–46. https://doi.org/10.1111/dme.14264.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). 2021. https://training.cochrane.org/handbook.
Cochrane Library. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2.0). 2019. https://methods.cochrane.org/risk-bias-20-tool.
Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—a randomized controlled trial. Patient Educ Couns. 2009;77(1):72–80. https://doi.org/10.1016/j.pec.2009.01.015.
Didjurgeit U, Kruse J, Schmitz N, Stuckenschneider P, Sawicki PT. A time-limited, problem-orientated psychotherapeutic intervention in type 1 diabetic patients with complications: a randomized controlled trial. Diabet Med. 2002;19(10):814–21. https://doi.org/10.1046/j.1464-5491.2002.00811.x.
Fisher L, Hessler D, Polonsky WH, et al. T1-REDEEM: a randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes. Diabetes Care. 2018;41(9):1862–9. https://doi.org/10.2337/dc18-0391.
Mohn J, Graue M, Assmus J, et al. The effect of guided self-determination on self-management in persons with type 1 diabetes mellitus and HbA1c ≥64 mmol/mol: a group-based randomised controlled trial. BMJ Open. 2017;7(6):e013295. https://doi.org/10.1136/bmjopen-2016-013295.
Morillas Jimenez V, Ruiz De Adana M, et al. Randomized trial to evaluate the addition of a mobile app (social diabetes) in adults with type 1 diabetes. Diabetes Technol Ther. 2020;22(Suppl 1):A-163. https://doi.org/10.1089/dia.2020.2525.abstracts.
Rondags SM, de Wit M, Twisk JW, Snoek FJ. Effectiveness of Hypoaware, a brief partly web-based psychoeducational intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a cluster randomized controlled trial. Diabetes Care. 2016;39(12):2190–6. https://doi.org/10.2337/dc16-1614.
Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns. 2006;64(1–3):78–86. https://doi.org/10.1016/j.pec.2005.11.017.
Zoffmann V, Vistisen D, Due-Christensen M. Flexible guided self-determination intervention for younger adults with poorly controlled type 1 diabetes, decreased HbA1c and psychosocial distress in women but not in men: a real-life RCT. Diabet Med. 2015;32(9):1239–46. https://doi.org/10.1111/dme.12698.
Ismail K, Thomas SM, Maissi E, et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Intern Med. 2008;149(10):708–19.
Menting J, Tack CJ, van Bon AC, et al. Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(6):448–56. https://doi.org/10.1016/S2213-8587(17)30098-0.
Petrak F, Herpertz S, Albus C, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the Diabetes and Depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care. 2015;38(5):767–75. https://doi.org/10.2337/dc14-1599.
van der Ven NC, Hogenelst MH, Tromp-Wever AM, et al. Short-term effects of cognitive behavioural group training (CBGT) in adult type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabet Med. 2005;22(11):1619–23. https://doi.org/10.1111/j.1464-5491.2005.01691.x.
Paschali AA, Peppou L, Benroubi M. Relaxation training significantly reduced blood glucose levels in patients with type 1 diabetes mellitus. Hormones. 2020;19(2):215–22. https://doi.org/10.1007/s42000-020-00187-w.
Bisno DI, Reid MW, Fogel JL, Pyatak EA, Majidi S, Raymond JK. Virtual group appointments reduce distress and improve care management in young adults with type 1 diabetes. J Diabetes Sci Technol. 2021;16(6):1419–27. https://doi.org/10.1177/19322968211035768.
Snoek FJ, Van Der Ven NCW, Twisk JWR, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA1c moderated by depression. A randomized controlled trial. Diabet Med. 2008;25(11):1337–42. https://doi.org/10.1111/j.1464-5491.2008.02595.x.
Efficace F, Cella D, Aaronson NK, et al. Impact of blinding on patient-reported outcome differences between treatment arms in cancer randomized controlled trials. J Natl Cancer Inst. 2022;114(3):471–4. https://doi.org/10.1093/jnci/djab177.
Yang X, Li Z, Sun J. Effects of cognitive behavioral therapy-based intervention on improving glycaemic, psychological, and physiological outcomes in adult patients with diabetes mellitus: a meta-analysis of randomized controlled trials. Front Psychiatry. 2020;11:711. https://doi.org/10.3389/fpsyt.2020.00711.
Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21(2):81–5. https://doi.org/10.1089/dia.2018.0310.
Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40(8):994–9. https://doi.org/10.2337/dc17-0636.
Hu H, Sawhney M, Shi L, et al. A systematic review of the direct economic burden of type 2 diabetes in china. Diabetes Ther. 2015;6(1):7–16. https://doi.org/10.1007/s13300-015-0096-0.
Wang W, Fu CW, Pan CY, et al. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health. 2009;12(6):923–9. https://doi.org/10.1111/j.1524-4733.2009.00561.x.
Menting J, Nikolaus S, Wiborg JF, et al. A web-based cognitive behaviour therapy for chronic fatigue in type 1 diabetes (Dia-Fit): study protocol for a randomised controlled trial. Trials. 2015;16:262. https://doi.org/10.1186/s13063-015-0764-4.
Guidi J, Brakemeier E-L, Bockting CL, et al. Methodological recommendations for trials of psychological interventions. Psychother Psychosom. 2018;87(5):276–84.
Alleaume C, Verger P, Peretti-Watel P. Psychological support in general population during the COVID-19 lockdown in France: needs and access. PLoS One. 2021;16(5):e0251707. https://doi.org/10.1371/journal.pone.0251707.